Indian fertility experts advise caution on clinical use of new 'Non-Invasive' Embryo Genetic Test

Leading Indian fertility experts have cautioned against using non-invasive embryo genetic testing (niPGT) for routine clinical decisions. A joint review by ISAR, IFS, and ACE found the technique prone to high misdiagnosis rates, potentially leading to incorrect embryo selection or discarding. The technology, while promising, lacks sufficient evidence for clinical use.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Y58haKj
via IFTTT

Read More

Budget for 'pharmacy of the world': What Sitharaman & Co can do to make medicines more affordable in India

Union Budget 2026: India's pharmaceutical landscape is on the brink of a transformative boom. To maintain this upward trajectory, the focus must shift towards fostering innovation and enhancing the efficiency of drug manufacturing. Strategic government funding is essential to bolster research initiatives, support production facilities, and strengthen healthcare frameworks.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fv9FTCQ
via IFTTT

Read More

India's hospital sector to sustain 11-12% growth, driven by insurance penetration and medical tourism: CareEdge

India's hospital sector is set for strong growth. Rising insurance and medical tourism are key drivers. Affordable treatment attracts global patients. Corporate hospitals show steady revenue gains. Bed capacity additions support future expansion. Financial health is improving with stable margins and reduced debt. This positive trend is expected to continue.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FW40j3y
via IFTTT

Read More

Ministry in talks with states to give some drug cos more time for good manufacturing practices compliance

The Union Health Ministry is in talks with states about extending the deadline for pharmaceutical companies to meet new manufacturing quality rules. A six-month extension may be granted on a case-by-case basis. This move aims to prevent potential medicine shortages and job losses. Many smaller drug units might otherwise face closure.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/b12VxAq
via IFTTT

Read More

Nimesulide banned: Govt puts a stop to manufacture, sale of all oral formulations containing the popular painkiller above 100 mg

Nimesulide sale banned: The move follows recommendation by India’s top research body- Indian Council of Medical Research (ICMR). In it’s earlier report to the drug regulatory body it had ecommended a total ban on all formulations of ninrsulide above 100 mg strength.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/sQ4ek7J
via IFTTT

Read More

Run, rave, repeat! Wellness turns social for Gen Z

Gen Z embraces wellness through social activities like pickleball and dance workouts. Brands are set to sponsor these events in 2026. Physical wellness is now a social identity. Gen Z is also choosing low and no-alcohol drinks. This zero-proof trend will continue. Non-alcoholic cocktails are emerging for social settings.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xgVRHDs
via IFTTT

Read More

Doctors warn against antibiotic misuse as resistance threat grows

Leading doctors are warning the public about the dangers of antibiotic resistance. They stress that antibiotics must only be used under a doctor's prescription. Careless use is making infections harder to treat. India is a major consumer of these medicines. Many hospital infections now resist common antibiotics. This misuse threatens future healthcare. Patients, doctors, and the industry must act responsibly.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/adJD7gC
via IFTTT

Read More